Lallemand Pharma

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Lallemand Pharma
Lallemand
  1. Lallemand Pharma
  2. Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone

News details

Dec
12,
2016

Value of adding a polyvalent mechanical bacterial lysate to therapy of COPD patients under regular treatment with salmeterol/fluticasone

Dec 12, 2016

© 2024 Lallemand Inc. All right reserved